• 1
    Lohr KN. Application of health status assessment measures in clinical practice: overview of the third conference on advances in health status assessment. Med Care 1992; 30 Suppl 5: MS114.
  • 2
    Deyo RA, Patrick DL. Barriers to use of the health status measures in clinical investigation, patient care and policy research. Med Care 1989; 27 Suppl 3: S25468.
  • 3
    Deyo RA, Carter WB. Strategies for improving and expanding the application of health status measures in clinical settings: a researcher-developer viewpoint. Med Care 1992; 30 Suppl 5: MS17686.
  • 4
    Fitzpatrick R, Fletcher A, Gore S, Jones D, Spiegelhalter D, Cox D. Quality of life measures in health care. I. Application and issues in assessment. BMJ 1992; 305: 10747.
  • 5
    Espallargues M, Valderas JM, Alonso J. Provision of feedback on perceived health status to health care professionals: a systematic review of its impact. Med Care 2000; 38: 17586.
  • 6
    McCarthy MJ, Shroyer AL, Sethi GK, Moritz TE, Henderson WG, Grover FL, et al. Self-report measures for assessing treatment outcomes in cardiac surgery patients. Med Care 1995; 33 Suppl 20: OS7685.
  • 7
    Burns R, Nichols L, Martindale-Adams J, Graney MJ. Interdisciplinary geriatric primary care evaluation and management: two year outcomes. J Am Geriatr Soc 2000; 48: 813.
  • 8
    McGowan JJ, Johnson-Lamarche H. The Senior Assessment Coupler: point of care decision support and data acquisition tool. Proc AMIA Symp 1999: 86872.
  • 9
    Frazer G, Brown C, Graves TK. Assessment of quality of life indicators among selected patients in a community cancer center. Issues Ment Health Nurs 1998; 19: 24162.
  • 10
    Block DE, Peterson J, Finch M, Kinney AM, Miller P, Cherveny J. The Bridge to Health Project: a collaborative model for assessing the health of a community. J Public Health Manag Pract 1998; 493: 439.
  • 11
    Wolinsky FD, Wan GJ, Tierney WM. Changes in the SF-36 in 12 months in a clinical sample of disadvantaged older adults. Med Care 1998; 36: 158998.
  • 12
    Gourley GA, Portner TS, Gourley DR, Rigolosi EL, Holt JM, Solomon DK, et al. Humanistic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc 1998; 38: 58697.
  • 13
    Cody M, McCombs JS, Parker JP. The Kaiser Permanente/USC Patient Consultation Study: change in quality of life. Am J Health Syst Pharm 1998; 55: 261520.
  • 14
    Shibley MC, Pugh CB. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners. Ann Pharmacother 1996; 30: 23843.
  • 15
    Jaber L, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann Pharmacother 1996; 30: 23843.
  • 16
    Buxton J, White M, Osoba D. Patients' experiences using a computerized program with a touch-sensitive video monitor for the assessment of health-related quality of life. Qual Life Res 1998; 7: 5139.
  • 17
    Ware JE, Snow KK, Kosinski M, Gandek B. Validity: norm-based interpretation. In: WareJE, editor. SF-36 Health Survey; manual and interpretation guide. Boston: The Health Institute, New England Medical Center; 1997. p. 138.
  • 18
    Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. DICP 1990; 11: 10937.
  • 19
    Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998; 41: 77899.
  • 20
    Stewart RB, Cooper JW. Polypharmacy in the aged. Drugs Aging 1994; 4: 44961.
  • 21
    Cadigan DA, Magaziner J, Fedder DO. Polymedicine use among community resident older women: how much of a problem. Am J Public Health 1989; 79: 153740.
  • 22
    Darnell JC, Murray MD, Martz BL, Weinberger M. Medication use by ambulatory elderly: an in-home survey. J Am Geriatr Soc 1986; 34: 14.
  • 23
    Hale WE, May FE, Marks RG, Stewart RB. Drug use in an ambulatory elderly population: a five year update. Drug Intell Clin Pharm 1987; 21: 5305.
  • 24
    Hanlon JT, Fillenbaum GG, Burchett B, Wall WE Jr, Service C, Blazer DG, et al. Drug use patterns among black and nonblack community-dwelling elderly. Ann Pharmacother 1992; 26: 67985.
  • 25
    Helling DK, Lemke JH, Semla TP, Wallace RB, Lipson DP, Cornoni-Huntley J. Medication use characteristics in the elderly: the Iowa 65+ Rural Health Study. J Am Geriatr Soc 1987; 35: 412.
  • 26
    Nolan L, O'Malley K. Prescribing for the elderly. Part I. Sensitivity of the elderly to adverse drug reactions. J Am Geriatr Soc 1988; 36: 1429.
  • 27
    Bluml BM, McKenney JM, Cziraky MJ. Pharmaceutical care services and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc 2000; 40: 15765.
  • 28
    Nola KM, Gourley DR, Portner TS, Gourley GK, Solomon DK, Elam M, et al. Clinical and humanistic outcomes of a lipid management program in the community pharmacy setting. J Am Pharm Assoc (Wash) 2000; 40: 16673.
  • 29
    Barnes J. Pharmacists' interventions can improve patient outcomes. PharmacoEconomics Outcomes News 1999; 235: 35.
  • 30
    Carter BL, Barnette DJ, Chrischilles E, Mazzotti G, Asali SJ. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy 1997; 17: 127485.
  • 31
    Rupp M, McCallian DJ, Sheth KK. Developing and marketing a community pharmacy-based asthma management program. J Am Pharm Assoc (Wash) 1997; NS37: 6949.
  • 32
    Ernst ME, Dourette WR, Dedhiya SD, Osterhaus MC, Kumbera PA, Osterhaus JT, et al. Use of point of service health status assessments by community pharmacists to identify and resolve drug-related problems in patients with musculoskeletal disorders. Pharmacotherapy 2001; 21: 9889.